Anixa Biosciences Inc.
News
We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate
Simply Wall St We can readily understand why investors are attracted to unprofitable companies. For example, although...\n more…
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
PR Newswire Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium Anixa Biosciences Announces Presentation on its...\n more…
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR Newswire Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire...\n more…
Anixa Biosciences, Inc. (NASDAQ:ANIX) Short Interest Up 33.0% in July
Ticker Report Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totalling 701,000 shares, a growth...\n more…
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Lewis H. Titterton, Jr. Acquires 21,646 Shares
Zolmax Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) Director Lewis H. Titterton, Jr. purchased 21,646 shares of the stock in a transaction on Tuesday, July 30th. The stock was acquired at an...\n more…
Lewis H. Titterton, Jr. Purchases 21,646 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) Stock
Ticker Report Anixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) Director Lewis H. Titterton, Jr. acquired 21,646 shares of the business's stock in a transaction on Tuesday, July 30th. The stock was acquired...\n more…